Cybin to Commence Trading on the NYSE American on August 5
Cybin Inc.(NEO: CYBN) (OTCMKTS: CLXPF), a biotechnology company focused on progressing psychedelic therapeutics, today announced that its common shares will open for trading on the NYSE American LLC stock exchange (“NYSE American”) on August 5, 2021, under the symbol “CYBN”.
In addition to listing and trading on the NYSE American in U.S. dollars, Cybin’s common shares will continue to be listed and trade in Canada on the NEO Exchange (“NEO”) in Canadian dollars under the symbol “CYBN”.
Shareholders that purchased their Cybin common shares “over-the-counter” or OTC, including shareholders whose shares are denoted in their institution/broker account with the symbol “CLXPF”, are advised to monitor their account to ensure their holdings are updated to reflect the NYSE American listing and trading symbol, as the Company expects OTC quotations for Cybin’s common shares to cease in connection with the NYSE American listing. Shareholders are advised to contact their broker for more information if they have questions in this regard.
Cybin’s common shares will also continue to trade on the Frankfurt Stock Exchange under the symbol “R7E1”.
About Cybin
Cybin is a leading biotechnology company focused on progressing psychedelic therapeutics by utilizing proprietary drug discovery platforms, innovative drug delivery systems, novel formulation approaches and treatment regimens for psychiatric disorders.
To view the original press release in its entirety click here
